LENALIDOMIDE IN THE TREATMENT OF RELAPSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)

被引:0
|
作者
Houillier, C. [1 ]
Choquet, S. [1 ]
Touitou, V. [1 ]
Martin-Duverneuil, N. [1 ]
Hoang-Xuan, K. [1 ]
机构
[1] Hop La Pitie Salpetriere, APHP, Paris, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P11.05
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Primary central nervous system lymphoma (PCNSL): Immunophenotypic and molecular genetic analysis
    Braaten, KM
    Betensky, R
    de Leval, L
    Okada, Y
    Hochberg, F
    Louis, D
    Harris, NL
    Batchelor, T
    [J]. LABORATORY INVESTIGATION, 2002, 82 (01) : 233A - 233A
  • [42] Primary central nervous system lymphoma (PCNSL): Immunophenotypic and molecular genetic analysis
    Braaten, KM
    Betensky, R
    de Leval, L
    Okada, Y
    Hochberg, F
    Louis, D
    Harris, NL
    Batchelor, T
    [J]. MODERN PATHOLOGY, 2002, 15 (01) : 233A - 233A
  • [43] Primäre Zentralnervensystemlymphome (PZNSL)Primary central nervous system lymphoma (PCNSL)
    A. Korfel
    U. Schlegel
    [J]. Der Onkologe, 2014, 20 : 75 - 86
  • [44] Characteristics and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)
    Sul, Joohee
    DeAngelis, Lisa M.
    Yahalom, Joachim
    Abrey, Lauren E.
    [J]. NEURO-ONCOLOGY, 2006, 8 (04) : 452 - 452
  • [45] Retrospective Study of 48 Cases of Primary Central Nervous System Lymphoma (PCNSL)
    Alessandro, Lucas
    Pastor Rueda, Jose
    Carpani, Federico
    Blaquier, Juan
    Tognarelli, Sofia
    Varela, Francisco
    Arakaki, Naomi
    Diez, Blanca
    Muggeri, Alejandro
    [J]. NEUROLOGY, 2016, 86
  • [46] Role of Rituximab in Treatment of Patients With Primary Central Nervous System Lymphoma (PCNSL): A Systematic Review and Meta
    Zhang, Yuhang
    Liu, Zhihe
    Gao, Chengwen
    Bian, Haiyan
    Ma, Yushuo
    Jing, Fanjing
    Zhao, Xia
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (10): : 733 - 741
  • [47] Severe complications after intrathecal methotrexate (MTX) for treatment of primary central nervous system lymphoma (PCNSL)
    Weigel, R
    Senn, P
    Weis, J
    Krauss, JK
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2004, 106 (02) : 82 - 87
  • [48] Relapsed Primary Central Nervous System Lymphoma: Current Advances
    Tao, Kaiyan
    Wang, Xuefeng
    Tian, Xin
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [49] PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL): CHARACTERISTICS AND OUTCOME IN A BELGIAN UNIVERSITY HOSPITAL
    Smets, Liesbeth
    Tousseyn, Thomas
    De Wolf-Peeters, Christiane
    Demaerel, Philippe
    Clement, Paul
    Verhoef, Gregor
    Dierickx, Daan
    [J]. ACTA CLINICA BELGICA, 2011, 66 (06): : 464 - 464
  • [50] Phase I clinical trial on pomalidomide and dexamethasone in treating patients with relapsed/refractory primary central nervous system lymphoma (PCNSL) or primary vitreoretinal lymphoma (PVRL).
    Tun, Han W.
    Johnston, Patrick B.
    Grommes, Christian
    Reeder, Craig B.
    Omuro, Antonio Marcilio Padula
    Menke, David M.
    Copland, John A.
    DeAngelis, Lisa Marie
    Witzig, Thomas E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35